Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Center for Cell-Based Therapy, National Cancer Institute, Bethesda, MD 20892, USA.
Science. 2019 Mar 29;363(6434). doi: 10.1126/science.aau0135.
A paradox of tumor immunology is that tumor-infiltrating lymphocytes are dysfunctional in situ, yet are capable of stem cell-like behavior including self-renewal, expansion, and multipotency, resulting in the eradication of large metastatic tumors. We find that the overabundance of potassium in the tumor microenvironment underlies this dichotomy, triggering suppression of T cell effector function while preserving stemness. High levels of extracellular potassium constrain T cell effector programs by limiting nutrient uptake, thereby inducing autophagy and reduction of histone acetylation at effector and exhaustion loci, which in turn produces CD8 T cells with improved in vivo persistence, multipotency, and tumor clearance. This mechanistic knowledge advances our understanding of T cell dysfunction and may lead to novel approaches that enable the development of enhanced T cell strategies for cancer immunotherapy.
肿瘤免疫学中的一个悖论是,浸润肿瘤的淋巴细胞在原位功能失调,但却具有类似于干细胞的行为,包括自我更新、扩增和多能性,从而导致大型转移性肿瘤的清除。我们发现,肿瘤微环境中钾的过度积累是这种二分法的基础,它触发了 T 细胞效应功能的抑制,同时保留了干细胞特性。高水平的细胞外钾通过限制营养物质的摄取来限制 T 细胞效应程序,从而诱导自噬和效应和衰竭部位组蛋白乙酰化的减少,这反过来又产生了具有改善体内持久性、多能性和肿瘤清除能力的 CD8 T 细胞。这种机制上的知识增进了我们对 T 细胞功能障碍的理解,并可能导致新的方法,使增强的 T 细胞策略能够用于癌症免疫治疗。
Front Immunol. 2019-11-26
Trends Immunol. 2013-11-6
Nat Immunol. 2025-7-23
Immunotargets Ther. 2025-6-27
Acta Pharm Sin B. 2025-4
Nat Rev Gastroenterol Hepatol. 2019-1
Science. 2018-3-23
Cell Metab. 2017-7-5